Antituberculosis-drug resistance
Geerligs, W.A.; van Altena, R.; van der Werf, T.S.
New England Journal of Medicine 339(15): 1079-1080
1998
ISSN/ISBN: 0028-4793 PMID: 9766995 Document Number: 485241
Document emailed within 1 workday
Related Documents
Micheletti, V.Celina.Dezoti.; Moreira, Jé.da.Silva.; Ribeiro, M.Osório.; Kritski, A.Lineu.; Braga, Jé.Ueleres. 2014: Drug-resistant tuberculosis in subjects included in the Second National Survey on Antituberculosis Drug Resistance in Porto Alegre, Brazil Jornal Brasileiro de Pneumologia: Publicacao Oficial da Sociedade Brasileira de Pneumologia e Tisilogia 40(2): 155-163Mohan, A.; Seth, S. 1998: Antituberculosis drug resistance: a global threat National Medical Journal of India 11(6): 276-277
Parra Rodríguez, J.C.; Ramírez Gavira, R.M.; Morales Acedo, M.J.; López Téllez, A. 2001: Profile of the patient with resistance to antituberculosis treatment in a basic health area Atencion Primaria 27(2): 146
Pillay, D.; Albert, J.; Bertagnolio, S.; Boucher, C.; Brun-Vezinet, F.; Clotet, B.; Giaquinto, C.; Perno, C.F. 2013: Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network Antiviral Therapy 18(6): 831-836
Hamers, R.L.; Schuurman, R.; Sigaloff, K.C.E.; Wallis, C.L.; Kityo, C.; Siwale, M.; Mandaliya, K.; Ive, P.; Botes, M.E.; Wellington, M.; Osibogun, A.; Wit, F.W.; van Vugt, M.èl.; Stevens, W.S.; de Wit, T.F.R. 2012: Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study LANCET. Infectious Diseases 12(4): 307-317
Choy, B.K.; McClarty, G.A.; Chan, A.K.; Thelander, L.; Wright, J.A. 1988: Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations Cancer Research 48(8): 2029-2035
Płocinska, R.; Korycka-Machala, M.; Plocinski, P.; Dziadek, J. 2017: Mycobacterial DNA Replication as a Target for Antituberculosis Drug Discovery Current Topics in Medicinal Chemistry 17(19): 2129-2142
Suzuki, K. 1998: Principles of antituberculosis chemotherapy and drug susceptibility tests Nihon Rinsho. Japanese Journal of Clinical Medicine 56(12): 3082-3086
Bertagnolio, S.; Rodriguez-Diaz, R.A.; Fuentes-Romero, L.L.; Bennett, D.E.; Viveros-Rogel, M.; Hart, S.; Pilon, R.; Sandstrom, P.; Soto-Ramirez, L.E. 2012: Transmitted HIV drug resistance among drug-naive subjects recently infected with HIV in Mexico City: a World Health Organization survey to classify resistance and to field test two alternative patient enrollment methods Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54(Suppl 4): S328-S333
Schutz, C.; Ismail, Z.; Proxenos, C.J.; Marais, S.; Burton, R.; Kenyon, C.; Maartens, G.; Wilkinson, R.J.; Meintjes, G. 2012: Burden of antituberculosis and antiretroviral drug-induced liver injury at a secondary hospital in South Africa South African Medical Journal 102(6): 506-511
Kuze, F.; Sakurai, N.; Ogino, F.; Togawa, S. 1986: Combined versus single-drug studies on susceptibilities of Mycobacterium avium-intracellulare to antituberculosis drugs on Ogawa medium Kekkaku: 61(6): 341-349
Ikuabe, P.O.; Ebuenyi, I.D.; Harry, T.C. 2015: Limited Elevations in Antituberculosis Drug-Induced Serum Alanine Aminotransferase (Alt) Levels in a Cohort of Nigerians on Treatment for Pulmonary Tuberculosis and HIV Infection in Yenagoa Nigerian Journal of Medicine: Journal of the National Association of Resident Doctors of Nigeria 24(2): 103-107
Foroumadi, A.; Soltani, F.; Moshafi, M.H. 2002: Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis Bollettino Chimico Farmaceutico 141(5): 394-396
Wang, F. 2006: To enhance the research of antibiotic resistance and infection caused by drug-resistance bacteria Zhonghua Yi Xue Za Zhi 86(9): 579-580
Baba, H. 1994: Studies on the problems of resistance to antituberculous drugs. II--1. Clinically applicable criteria of drug-resistance to rifampicin Kekkaku: 69(6): 387-396
Harada, Y.; Kitahara, Y.; Ninomiya, H.; Harada, S.; Takamoto, M.; Ishibashi, T. 1994: A study on drug resistance of newly admitted pulmonary tuberculosis patients with special reference to the resistance to SM, INH, EB and RFP Kekkaku: 69(12): 751-757
Rabinovich, S.A. 1976: Drug resistance in malaria parasites. 1. The nature of resistance, its distribution and epidemiological implications (review of the literature) Meditsinskaia Parazitologiia i Parazitarnye Bolezni 45(4): 464-477
Danks, M.K.; Yalowich, J.C.; Beck, W.T. 1987: Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM-26) Cancer Research 47(5): 1297-1301
Li, J.; Ma, Y.-x.; Zhang, Q.-b.; Zhou, Y.-a.; Shang, R.-p.; Li, P.-l.; Hao, Z.-q. 2013: Correlations of integrons and resistance gene cassettes in Gram-negative bacteria with multi-drug resistance Zhonghua Yi Xue Za Zhi 93(46): 3698-3702
Hamers, R.L.; Straatsma, E.; Kityo, C.; Wallis, C.L.; Stevens, W.S.; Sigaloff, K.C.E.; Siwale, M.; Conradie, F.; Botes, M.E.; Mandaliya, K.; Wellington, M.; Osibogun, A.; van Vugt, M.èl.; Rinke de Wit, T.F. 2012: Building capacity for the assessment of HIV drug resistance: experiences from the PharmAccess African Studies to Evaluate Resistance network Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54(Suppl 4): S261-S265